Dr. Reddy’s and Hetero partner with Gilead Sciences to manufacture and distribute Lenacapavir for HIV treatment in LMICs.

Gilead Sciences first launched lenacapavir under the brand name Sunlenca in the United States and European markets in 2022.

Lenacapavir is a US Food and Drug Administration (FDA) approved medication indicated for the treatment of HIV type 1 (HIV-1) ...

Dr Reddy’s Laboratories said it has entered into a royalty-free non-exclusive voluntary licensing agreement with Gilead ...

Dr Reddy's Laboratories on Wednesday said it has tied up with Gilead Sciences for the manufacture and commercialisation of ...

Large cap FMCG giant Nestle India Ltd will consider its financial results for July to September 2024 quarter on October 17, ...

Athens hosted the event, which saw students gathered from more than 190 countries around the world. The event aims to inspire ...

Hyderabad: Dr. Nilay Reddy, a senior doctor at LV Prasad Eye Hospital, was killed in a fatal road accident near Himayathsagar ...

Telangana to organise 3-day G-SPARC 2024 from Oct 3-5 to highlight infection control and AMR: Our Bureau, Bengaluru Tuesday, October 1, 2024, 14:15 Hrs [IST] Telangana will organi ...

Only when you choose a developer known for quality and timely service can you truly enjoy peace of mind in your new home. One such name, synonymous with transparency and trust, is V2 Holdings Housing ...

Dr. Nilay Reddy, 29, a Cornea and Anterior Segment Fellow at the LV Prasad Eye Hospital, was travelling to the airport from ...

Hyderabad: The Dr M. Channa Reddy Memorial Trust said it would organise a round table meeting on the Four Water Concept ...